markov microsimulation model tree age pro 2020 (treeage software)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

treeage software markov microsimulation model tree age pro 2020
Markov Microsimulation Model Tree Age Pro 2020, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/markov+microsimulation/markov+simulation+model+treeage+pro+2008/pm37993164-46-1-4
Average 90 stars, based on 1 article reviews

markov microsimulation model tree age pro 2020 - by Bioz Stars, 2026-09

90/100 stars

Images

other:

Article Title: Bariatric Surgery Prior to Total Hip Arthroplasty Is Cost-Effective in Morbidly Obese Patients.
Article Snippet: Background: The cost-effectiveness of bariatric surgery to achieve weight loss prior to total hip arthroplasty (THA), and decrease the complications and costs associated with THA in the morbidly obese, is unknown.. This study evaluated the cost-effectiveness of bariatric surgery prior to THA for morbidly obese patients with end-stage hip osteoarthritis (OA).. Methods: A state-transition Markov model was constructed to compare the cost-utility of 2 treatment protocols for patients with morbid obesity and end-stage hip OA: (1) immediate THA and (2) bariatric surgery 2 years prior to THA (combined protocol).

Article Title: Early offering transcatheter aortic valve replacement to patients with moderate aortic stenosis: quantifying costs and benefits – a Markov model-based simulation study
Article Snippet: A Markov microsimulation model (Tree Age Pro 2020, Tree Age, Williamstown, Massachusetts, USA) was developed to simulate a hypothetical cohort of 10 000 patients over a lifetime horizon of 15 years, one year cycle length and 5% discount rate ( ).

Article Title: Early offering transcatheter aortic valve replacement to patients with moderate aortic stenosis: quantifying costs and benefits - a Markov model-based simulation study.
Article Snippet: A Markov microsimulation model (Tree Age Pro 2020, Tree Age, Williamstown, Massachusetts, USA) was developed to simulate a hypothetical cohort of 10 000 patients over a lifetime horizon of 15 years, one year cycle length and 5% discount rate (figure 1).9 The time horizon was determined on the available evidence reported on median life expectancy of patients who undergone SAVR in the literature.10 The model structure was adapted from a similar decision- analytic model, used to compare immediate AVR for asymptomatic AS versus watchful waiting.11 Patients start in the model with either early TAVI or watchful waiting with late TAVI on progression into a more severe AS stage with changes in valve haemodynamic.

Article Title: Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.
Article Snippet: Building the Markov microsimulation model in TreeAge Pro 2019 R1.0 (TreeAge Software Inc., Williamstown, MA, USA) enabled us to keep track of the treatment history, time since last treatment and recurrence of simulated patients, which all have an impact on the cost and effect estimates.

Article Title: Cost-effectiveness of alternative anticoagulation strategies for postoperative management of total knee arthroplasty patients
Article Snippet: We constructed a probabilistic, Markov, state-transition computer simulation model (TreeAge Pro© 2017).

Software:

Article Title: Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
Article Snippet: .. According to the HYPO-RT-PC trial (ISRCTN45905321) protocol, a Markov model programmed in TreeAge Pro software 2011 (TreeAge Software LLC, Williamstown, MA, USA) was used for comparing the economic consequences and therapeutic efficacy of ultra-hypofractionated radiotherapy from the Chinese payer’s perspective ( ). ..

Article Title: Cost-Effectiveness of Routine Monitoring of Long-Term Conditions in Primary Care: Informing Decision Modelling with a Systematic Review in Hypertension, Type 2 Diabetes and Chronic Kidney Disease
Article Snippet: .. Kessler et al. (2012) [ ], Switzerland , Microsimulation model (adapted from a US CKD model [[ ]] ) TreeAge Pro 2008 software , No explicit rationale given , No CKD; CKD stages 1–5; stroke; CHD; death , Lifetime (until age 90 years or death) horizon Discounted at 3% per year (0–5% in sensitivity analysis) , Not available in this publication , Suboptimal treatment adherence is incorporated by the assumption that only 75% of subjects will initiate ACE inhibitor or ARB treatment after diagnosis. .. NICE (2021) [ ], UK , Rule-based algorithm and Markov cohort model with a cycle length of 3 months Software not reported , No explicit rationale given , Dialysis Markov model: dialysis; transplant; dead Pre-emptive transplant Markov model: living donor transplant; deceased donor transplant; post graft failure; dead , Lifetime horizon Discounted at 3.5% , Not available in this publication , Model assumes that eGFR and ACR progression for individuals can reasonably be approximated using average population declines.

Drug discovery:

Construct:

Article Title: Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma.
Article Snippet: Accepted Manuscript Title: Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma Authors: Alessandro Cucchetti MD Franco Trevisani MD, PhD Alberta Cappelli MD Cristina Mosconi MD Matteo Renzulli MD Antonio Daniele Pinna MD Rita Golfieri MD PII: S1590-8658(15)30305-4 DOI: http://dx.doi.org/doi:10.1016/j.dld.2016.03.031 Reference: YDLD 3149 To appear in: Digestive and Liver Disease Received date: 27-10-2015 Revised date: 18-3-2016 Accepted date: 30-3-2016 Please cite this article as: Cucchetti A, Trevisani F, Cappelli A, Mosconi C, Renzulli M, Pinna AD, Golfieri R, Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinoma, Digestive and Liver Disease (2016), http://dx.doi.org/10.1016/j.dld.2016.03.031 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form.

Review

markov microsimulation model tree age pro 2020 (treeage software)

Structured Review

Images

Related Articles

other:

Software:

Drug discovery:

Construct:

Biomarker Discovery:

Similar Products

Image Search Results